Dosing has begun in a new regimen of the HEALEY ALS platform trial, its ninth, which is testing the oral therapy NUZ-001 for ...
News-Medical.Net on MSN
Researchers identify TRIM13 protein as key driver of immune suppression in sepsis
Dendritic cells (DCs) are increasingly recognized as important contributors to sepsis-associated immune dysfunction. As professional antigen-presenting cells, they bridge innate sensing and durable ...
Sepsis remains a major challenge in modern medicine, claiming millions of lives each year. For decades, clinical management ...
Dr. Todd Maderis, ND Exploring immune dysregulation, viral reactivation, mitochondrial impairment, and treatment implications in post-EBV fatigue syndromes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results